2.29% 0.065

Esperion Therapeutics Inc (ESPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ESPR Giù? Forum Previsione Frazionamento azionario

Esperion Therapeutics Inc Azioni (ESPR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	92.93% 168.45	87.31	-	65.00	69.11
Operating Expenses	14.45% 83.21	97.27	-	87.09	73.53
Benefits Costs and Expenses	423.98	-	-	-	-
Costs And Expenses	68.94% 164.33	97.27	-	87.09	73.53
Operating Income/Loss	955.84% 85.23	-9.959	-	-22.10	-4.42
Income/Loss From Continuing Operations Before Tax	392.67% -255.53	87.31	-12.72	-40.45	69.11
Income Tax Expense/Benefit	1.841	-	-	-	-
Income/Loss From Continuing Operations After Tax	297.34% 61.83	-31.33	-12.72	-40.45	-21.32
Net Income/Loss	297.34% 61.83	-31.33	-12.72	-40.45	-21.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.16% 9.7114	200.74	-	196.13	2.8154
Diluted Average Shares	95.16% 9.7114	200.74	-	196.13	2.8154
Basic Earnings Per Share	300.00% 0.32	-0.16	-	-0.21	-0.11
Diluted Earnings Per Share	300.00% 0.32	-0.16	-	-0.21	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RDY

$13.95

3.72%

RGC

$25.01

0.81%

ELAN

$25.30

1.02%

NBIX

$130.03

1.78%

VTRS

$13.60

1.72%

UTHR

$537.49

3.12%